Zi-Yu Li Selected Research

XELOX

1/2022

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zi-Yu Li Research Topics

Disease

23	Stomach Neoplasms (Stomach Cancer) 07/2023 - 12/2010
16	Neoplasms (Cancer) 09/2022 - 05/2011
10	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2010
6	Adenocarcinoma 12/2021 - 12/2013
3	Sepsis (Septicemia) 09/2022 - 10/2020
2	Inflammation (Inflammations) 09/2022 - 01/2022
2	Spinal Cord Injuries (Spinal Cord Injury) 09/2022 - 01/2022
2	Cicatrix (Scar) 09/2022 - 01/2022
2	Rectal Neoplasms (Rectal Cancer) 02/2021 - 02/2015
2	Wounds and Injuries (Trauma) 01/2020 - 02/2015
2	Carcinogenesis 01/2015 - 01/2015
1	Septic Shock (Toxic Shock Syndrome) 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Shock 03/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020
1	Intraoperative Complications 11/2020
1	Ulcer 01/2020
1	Hemorrhage 01/2020
1	Carcinoma (Carcinomatosis) 08/2018
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Metaplasia 12/2013
1	Lymphatic Metastasis 12/2013
1	Retinoblastoma (Glioblastoma, Retinal) 01/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 07/2023 - 12/2013
3	Imatinib Mesylate (Gleevec)FDA Link 09/2022 - 10/2013
3	Capecitabine (Xeloda)FDA Link 01/2022 - 02/2015
2	Carcinoembryonic AntigenIBA 07/2023 - 05/2013
2	human ERBB2 proteinIBA 01/2023 - 05/2011
2	MicroRNAs (MicroRNA)IBA 12/2022 - 12/2020
2	CreatinineIBA 09/2022 - 03/2021
2	matrigelIBA 01/2015 - 01/2015
2	EnzymesIBA 01/2015 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 05/2011
1	CarbohydratesIBA 07/2023
1	AntigensIBA 07/2023
1	Becaplermin (PDGF-BB)FDA Link 09/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	metuximabIBA 01/2022
1	XELOXIBA 01/2022
1	Chondroitin Sulfate ProteoglycansIBA 01/2022
1	ProcalcitoninIBA 03/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2021
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	Minichromosome Maintenance Complex Component 7IBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2016
1	Leucine (L-Leucine)FDA Link 12/2013
1	vasectrin IIIIBA 12/2013
1	Formaldehyde (Formol)FDA Link 12/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2013
1	Fluorouracil (Carac)FDA LinkGeneric 12/2010
1	Docetaxel (Taxotere)FDA Link 12/2010
1	Cisplatin (Platino)FDA LinkGeneric 12/2010

Therapy/Procedure

14	Neoadjuvant Therapy 07/2023 - 08/2011
7	Gastrectomy 04/2021 - 09/2011
6	Drug Therapy (Chemotherapy) 01/2022 - 12/2010
5	Therapeutics 01/2022 - 04/2015
4	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 02/2013
2	Adjuvant Chemotherapy 01/2022 - 05/2013
2	Length of Stay 10/2020 - 01/2017
1	Radiotherapy 02/2021
1	Splenectomy 11/2020
1	Conversion to Open Surgery 11/2020
1	Hemostatic Techniques 01/2020
1	Electrocoagulation (Electrocautery) 01/2020
1	Induction Chemotherapy 09/2016
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2015
1	Proctectomy 02/2015
1	Cytoreduction Surgical Procedures 02/2013
1	Hyperthermic Intraperitoneal Chemotherapy 02/2013